Neuroendocrine Tumor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CRNX | C | Crinetics Pharmaceuticals, Inc. | 5.36 | |
AQST | C | Aquestive Therapeutics, Inc. | 3.90 | |
ABUS | D | Arbutus Biopharma Corporation | -0.77 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | C | ALPS Medical Breakthroughs ETF | 2.11 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 1.47 | |
XBI | C | SPDR S&P Biotech ETF | 1.07 | |
GERM | F | ETFMG Treatments Testing and Advancements ETF | 0.99 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 0.95 |
Compare ETFs
Related Industries:
Biotechnology
- Neuroendocrine Tumor
A neuroendocrine tumor (NET) is a type of cancer that develops from cells of the neuroendocrine system. This system is made up of cells that release hormones in response to signals from the nervous system. Neuroendocrine tumors can occur anywhere in the body and can be benign (non-cancerous) or malignant (cancerous). Symptoms of NETs vary depending on the location and type of tumor, but may include abdominal pain, diarrhea, weight loss, and fatigue. Treatment options may include surgery, chemotherapy, radiation, and targeted therapy.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles